Patients' Health May Be Jeopardized By High Leukemia Treatment Costs

The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under - or untreated because they cannot afford care, according to a Blood Forum article supported by nearly 120 CML experts from more than 15 countries on five continents and published online in Blood, the Journal of the American Society of Hematology (ASH)... via Health News from Medical News Today Read More Here..